TRIB3 and glioblastoma: Bioinformatic analyses of public databases combining mRNA/protein expression of TRIB3 are upregulated in GBM patient samples and increase the poor prognosis of GBM patients, suggesting that TRIB3 may function as a tumor promoter and may have therapeutic value.